ArticleMovement disorders clinical practice2025

Navigating the Neuropsychiatric Risks of Foslevodopa/Foscarbidopa in Patients with Parkinson's Disease.

Paolo Solla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.